DC-SIREN
Siren, the company that provides an all-in-one investigation platform to Police and Sheriff's Departments, Intelligence and Law Enforcement Agencies, Fusion Centers and High Intensity Drug Trafficking Areas programs (HIDTAs) has launched a new AI-Powered search with mobile access as part of its latest release and its Siren for Law Enforcement product bundle.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240125060576/en/
New Simplified Search (Photo: Business Wire)
Siren provides a complete suite of investigation tools for contemporary challenges such as police vetting, “Smash and Grab” violence, VIP protection, trafficking, supply chain rime and maritime security.
Siren connects local classified information with external vendor data as well as data available from public sources (OSINT), to identify patterns, actors and events. Siren is now available on mobile devices to provide an additional layer of safety for front line officers.
The new AI-driven search dramatically reduces the complexity in connecting disparate intelligence. Complex links can be made by anyone from any department, using a basic language based search and without the need for analytical skills. According to Siren’s research, it takes at least six months for a new analyst to become productive. The simple interface naturally distributes the workload.
Siren makes it possible for front-line officers to background check suspects, companies and properties from a mobile device prior to criminal interactions and site raids. The new Siren innovation offers an extra layer of security, reducing the risk of unexpected dangers and providing fast actionable leads.
"Simple is hard and that’s what we have achieved with Siren 14.” said John Randles, CEO of Siren. “Siren can now provide complex connected intelligence to Command Staff and Uniformed Police without data science training. It’s a simple search just like using the internet or shopping online.” he concluded.
“The new ability to search in Siren will push the control of basic investigations and safety checks back out into the hands of those who need it most.” said Siren customer, Kathleen Miles, Head of Client Relations, and Co-Founder of Ex Arca, an open-source research firm. “Siren mobile means that intelligence teams can focus on the work they are trained to do.” she added.
"Siren is now accessible to the whole department which is a complete game changer. Democratising intelligence like this is a change not seen in twenty years of technology." commented Bob Griffin, Chairman of Siren.
About Siren
Siren is an all-in-one investigation platform used by law enforcement, intelligence agencies and corporations to safeguard people, assets and networks. Siren links data from open source, vendors and classified sources to surface unconnected intelligence. Siren’s patented technology is uniquely search-based providing a simple interface and advanced reporting for investigations at Enterprise speed and scale.
In November 2023, Siren achieved 9th in Deloitte’s Technology Fast 50. Siren received €12 million funding in 2023 and was named a Gartner Cool Vendor in 2020. For more information, visit www.siren.io.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240125060576/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body5.12.2025 07:00:00 CET | Press release
Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1 Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs The certification validates Sculptra’s safety performance, efficacy, and quality, reinforcing Galderma’s commitment to innovation and meeting evolving patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its
Northern Escape Heli-Skiing Takes the Title of “World’s Best Heli-Ski-Operator” for the 4th Year Running5.12.2025 02:40:00 CET | Press release
4x World’s Best Heli-Skiing Operation near Terrace, BC Northern Escape Heli-Skiing (NEH) has been named World’s Best Heli-Ski Operator 2025 by the World Ski Awards, marking its fourth straight victory following years 2022, 2023 and 2024. This recognition places NEH amongst an elite group of ski tourism operators consistently voted best in the world by industry leaders and enthusiasts alike. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204074550/en/ A four-year run built on reliability NEH operates in British Columbia’s Skeena Mountains, where deep northern snow and vast terrain come together with small-group heli-skiing and heli snowboarding. When helicopters can’t safely fly, NEH has cat skiing readily available as a backup — an exceedingly rare offering in this industry. The operation spans over 833,571 wild acres of alpine bowls, glaciers and old-growth tree skiing. The NEH experience Guests choose from three lodge f
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance5.12.2025 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollment in Q1 2026, initially evaluating patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck, and ovarian/gynecological cancers. IDE034 is a bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and licensed to IDEAYA in July 2024. The IND clearance marks an important milestone for this licensed program, supporting subsequent clinical development of IDE034, while highlighting Biocytogen’s technical capabilities in bispecific ADC discovery and development. Dr. Yue
Helical Fusion, Developer of Next-Generation Clean Energy Through Nuclear Fusion, Completes USD 5.5M Series A Extension Round5.12.2025 01:00:00 CET | Press release
Stakeholder base expands with participation from an individual-investor-oriented fund, alongside corporate and individual investors, bringing Total Funding to USD 38M Helical Fusion Co., Ltd. (Head Office: Chuo-ku, Tokyo; CEO: Takaya Taguchi; hereafter “Helical Fusion”), which is developing a next-generation energy source using Japan’s original Helical Stellarator technology to realize commercially viable fusion power plant in the 2030s, announced the completion of its Series A Extension round, raising approximately USD 5.5 million (≈ JPY 870 million). The round included investments from “Ecrowd NEXT”, a fund designed for individual investors, as well as multiple corporate investors and individual investors. As a result, Helical Fusion’s total Series A funding, including loans, amounts to approximately USD 21 million (≈ JPY 3.2 billion), bringing the company’s cumulative fundraising—including grants and loans—to approximately USD 38 million (≈ JPY 6.0 billion). With this funding, Helic
Andersen Consulting udvider sin tilstedeværelse gennem samarbejde med Hilal Technology4.12.2025 23:04:00 CET | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Hilal Technology for at styrke sine kompetencer inden for digital infrastruktur, cybersikkerhed og AI. Med tilstedeværelse i Bahrain, Saudi-Arabien, De Forenede Arabiske Emirater, Oman og Indien leverer Hilal Technology et komplet spektrum af digital infrastruktur og managed services inden for cloudcomputing, cybersikkerhed, enterprise ai og systemintegration. Deres ydelser omfatter cloudtjenester, sikkerheds- og netværksdrift, implementering af ERP og applikationer samt udvikling af generative ai-kapaciteter. Med et team på mere end 250 fagfolk servicerer firmaet en bred vifte af brancher, herunder den finansielle sektor, olie og gas, logistik og den offentlige sektor. "Transformation er mere end systemer; det handler om parathed, tillid og løbende samarbejde," udtaler Roshan George, direktør for Hilal Technology. "Vi er begejstrede for at samarbejde med Andersen Consulting og levere skalerbare løsninger, der matcher tempoet i den dig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom